Table 2

Selected associations between genetic variants and capecitabine toxicity in QUASAR2

GeneSNP
b37 coordinate
Toxicity- associated allele/other alleleTAFn Genotyped
n imputed
Info score
A=Hap370
B=Hap610
C=Omni2.5
Global binary: 012v34
OR (95% CI)
p-value
Global quant:01v2v34
OR (95% CI)
p-value
HFS binary:012v34
OR (95% CI)
p-value
HFS quant:01v2v34
OR (95% CI)
p-value
Diarrhoea binary:012v34
OR (95% CI)
p-value
Diarrhoea quant:01v2v34
OR (95%CI)
p-value
Other clinically actionable associations
DPYDrs12132152
chr1:97523004
A/G0.031456
484
0.993A3.83 (3.26–4.40)1.61 (1.41–1.82)6.12 (5.48–6.76)1.74 (1.53–1.95)0.44 (0–1.32)0.85 (0.68–1.02)
4.31×10−65.89×10−63.29×10−81.47×10−70.0650.068
DPYDrs76387818
chr1:97539400
A/G0.0310
940
0.993A
0.999B
0.999C
4.05 (3.47–4.62)1.66
(1.45–1.87)
6.44
(5.79–7.09)
1.78
(1.57–1.99)
0.44
(0–1.33)
0.86 (0.68–1.03)
2.11×10−61.93×10−61.75×10−85.51×10−80.0710.083
DPYDrs7548189
chr1:97 867 713
A/C0.196940
0
N/A1.67 (1.43–1.91)1.23 (1.14–1.31)1.42 (1.15–1.69)1.16 (1.07–1.25)1.21 (0.84–1.58)1.18 (1.10–1.25)Diarrhoea 01v234
1.76 (1.50–2.02)
3.79×10−56.82×10−60.0110.00110.00151.54×10−51.72×10−5
DPYDrs12 022 243
chr1: 97 862 780
T/C0.1960
940
0.996A
0.992B
0.998C
1.69 (1.45–1.94)1.23 (1.14–1.32)1.43 (1.16–1.7)1.16 (1.07–1.25)1.79 (1.54–2.05)1.18 (1.11–1.26)
2.55 x10−54.45 x10−60.00968.26 x10−49.86 x10−61.11 x10−5
TYMS/ENOSF1rs2612091
chr18:683 607
C/T0.532940
0
N/A1.59 (1.39–1.79)
5.28×10−6
1.19 (0.77–0.91)
2.35×10−6
1.57 (0.45–0.83)
2.94×10−6
1.21 (0.76–0.90)
3.67×10−7
1.18 (0.55–1.15)
0.29
1.04 (0.90–1.03)
0.27
HFS 01v234
1.57 (0.45–0.83)
2.94×10−6
TYMS/ENOSF1rs2741171
chr18:700 687
T/C0.5340
940
0.960A
0.975B
0.990C
1.60 (1.39–1.80)
6.64×10−6
1.20 (1.13–1.28)
9.24×10−7
1.74 (1.51–1.97)
1.64×10−6
1.23 (1.16–1.31)
3.10×10−8
1.01 (0.70–1.32)
0.92
1.03 (0.97–1.09)
0.37
HFS 01v234
1.61 (1.42–1.80)
1.44×10−6
  • The table shows the results of the meta-analysis of global and selected individual toxicities, measured as binary or continuous (‘quant’) variables, in the two arms of QUASAR2. The frequency of the toxicity-associated allele (TAF) is also shown and ORs are expressed relative to this. Imputation quality Info Score is also shown, as are numbers of samples imputed and directly genotyped. The final column shows results for toxicity phenotype classifications that could lead to treatment change or delay according to the QUASAR2 protocol. There was no evidence of heterogeneity between QUASAR2 arms in any of these analyses Phet>0.2, I2<0.25).